The Vitamin D Receptor Interacts Preferentially with DRIP205-like LxxLL Motifs

Overview

Journal Arch Biochem Biophys

Publisher Elsevier

Specialties Biochemistry
Biophysics

Date 2007 Jan 27

PMID 17254542

Citations 8

Authors

Lee A Zella

Ching-Yi Chang

Donald P McDonnell

J Wesley Pike

Affiliations

Soon will be listed here.

Abstract

The vitamin D receptor (VDR) mediates the biological actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) through its capacity to recruit coregulatory proteins. This interaction is mediated via a coregulatory LxxLL motif. We screened a combinatorial (x)7LxxLL(x)7 phage library with purified VDR to identify peptides that displayed high affinity and selectivity for VDR. These peptides contained the consensus sequence Lx E/H x H/F P L/M/I LxxLL and exhibited significant sequence similarity to the active LxxLL box found in DRIP205. Nearly all LxxLL peptides interacted in a ligand-dependent manner directly with human VDR. However, a pattern of selectivity of the peptides for other members of the nuclear receptor family was also observed. Interestingly, the interaction between the VDR and many of the peptides was differentially sensitive to a broad assortment of VDR ligands. Finally, several of these peptides were shown to inhibit activation of a 1,25(OH)2D3-sensitive reporter gene. These studies suggest that the LxxLL motif can interact directly with the VDR and that this interaction is regulated by chemically diverse vitamin D ligands.

Citing Articles

The SARS-CoV-2 spike protein binds and modulates estrogen receptors.

Solis O, Beccari A, Iaconis D, Talarico C, Ruiz-Bedoya C, Nwachukwu J Sci Adv. 2022; 8(48):eadd4150.

PMID: 36449624 PMC: 9710872. DOI: 10.1126/sciadv.add4150.

The SARS-CoV-2 spike protein binds and modulates estrogen receptors.

Solis O, Beccari A, Iaconis D, Talarico C, Ruiz-Bedoya C, Nwachukwu J bioRxiv. 2022; .

PMID: 35665018 PMC: 9164441. DOI: 10.1101/2022.05.21.492920.

Alternative binding sites at the vitamin D receptor and their ligands.

Mutchie T, Yu O, Di Milo E, Arnold L Mol Cell Endocrinol. 2019; 485:1-8.

PMID: 30654005 PMC: 6444937. DOI: 10.1016/j.mce.2019.01.011.

Inhibitors for the Vitamin D Receptor-Coregulator Interaction.

Teske K, Yu O, Arnold L Vitam Horm. 2016; 100:45-82.

PMID: 26827948 PMC: 4740976. DOI: 10.1016/bs.vh.2015.10.002.

1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components.

Lee S, Riley E, Meyer M, Benkusky N, Plum L, Deluca H J Biol Chem. 2015; 290(29):18199-18215.

PMID: 26041780 PMC: 4505063. DOI: 10.1074/jbc.M115.665794.

References

Vanhooke J, Benning M, Bauer C, Pike J, Deluca H . Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry. 2004; 43(14):4101-10. DOI: 10.1021/bi036056y. View

Pathrose P, Barmina O, Chang C, McDonnell D, Shevde N, Pike J . Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors. J Bone Miner Res. 2002; 17(12):2196-205. DOI: 10.1359/jbmr.2002.17.12.2196. View

Evans R . The steroid and thyroid hormone receptor superfamily. Science. 1988; 240(4854):889-95. PMC: 6159881. DOI: 10.1126/science.3283939. View

Hall J, Chang C, McDonnell D . Development of peptide antagonists that target estrogen receptor beta-coactivator interactions. Mol Endocrinol. 2000; 14(12):2010-23. DOI: 10.1210/mend.14.12.0561. View

Aranda A, Pascual A . Nuclear hormone receptors and gene expression. Physiol Rev. 2001; 81(3):1269-304. DOI: 10.1152/physrev.2001.81.3.1269. View

Tocchini-Valentini G, Rochel N, Wurtz J, Moras D . Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a.... J Med Chem. 2004; 47(8):1956-61. DOI: 10.1021/jm0310582. View

Haussler M, Whitfield G, Haussler C, Hsieh J, Thompson P, Selznick S . The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998; 13(3):325-49. DOI: 10.1359/jbmr.1998.13.3.325. View

Shiau A, Barstad D, Loria P, Cheng L, Kushner P, Agard D . The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 1999; 95(7):927-37. DOI: 10.1016/s0092-8674(00)81717-1. View

Torchia J, Rose D, Inostroza J, Kamei Y, Westin S, Glass C . The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 1997; 387(6634):677-84. DOI: 10.1038/42652. View

10.

Kim S, Shevde N, Pike J . 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res. 2005; 20(2):305-17. DOI: 10.1359/JBMR.041112. View

11.

Yamamoto H, Shevde N, Warrier A, Plum L, Deluca H, Pike J . 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J Biol Chem. 2003; 278(34):31756-65. DOI: 10.1074/jbc.M304737200. View

12.

Glass C . Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev. 1994; 15(3):391-407. DOI: 10.1210/edrv-15-3-391. View

13.

Pike J, Pathrose P, Barmina O, Chang C, McDonnell D, Yamamoto H . Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription. J Cell Biochem. 2003; 88(2):252-8. DOI: 10.1002/jcb.10336. View

14.

Herdick M, Steinmeyer A, Carlberg C . Antagonistic action of a 25-carboxylic ester analogue of 1alpha, 25-dihydroxyvitamin D3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators. J Biol Chem. 2000; 275(22):16506-12. DOI: 10.1074/jbc.M910000199. View

15.

Deluca H . Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004; 80(6 Suppl):1689S-96S. DOI: 10.1093/ajcn/80.6.1689S. View

16.

Norris J, Paige L, Christensen D, Chang C, Huacani M, Fan D . Peptide antagonists of the human estrogen receptor. Science. 1999; 285(5428):744-6. DOI: 10.1126/science.285.5428.744. View

17.

Heery D, Kalkhoven E, Hoare S, Parker M . A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 1997; 387(6634):733-6. DOI: 10.1038/42750. View

18.

Jurutka P, Whitfield G, Hsieh J, Thompson P, Haussler C, Haussler M . Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord. 2001; 2(2):203-16. DOI: 10.1023/a:1010062929140. View

19.

Pirozzi G, MCCONNELL S, Uveges A, Carter J, Sparks A, Kay B . Identification of novel human WW domain-containing proteins by cloning of ligand targets. J Biol Chem. 1997; 272(23):14611-6. DOI: 10.1074/jbc.272.23.14611. View

20.

Mangelsdorf D, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K . The nuclear receptor superfamily: the second decade. Cell. 1995; 83(6):835-9. PMC: 6159888. DOI: 10.1016/0092-8674(95)90199-x. View